Nordea Investment Management AB raised its holdings in Stryker Corporation (NYSE:SYK) by 18.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,333 shares of the medical technology company’s stock after acquiring an additional 2,954 shares during the period. Nordea Investment Management AB’s holdings in Stryker were worth $2,746,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Stryker by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after acquiring an additional 657,656 shares during the last quarter. BlackRock Inc. raised its holdings in Stryker by 5.2% in the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after acquiring an additional 1,139,082 shares during the last quarter. Jensen Investment Management Inc. raised its holdings in Stryker by 11.3% in the 3rd quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock valued at $351,141,000 after acquiring an additional 251,685 shares during the last quarter. Legal & General Group Plc raised its holdings in Stryker by 4.7% in the 2nd quarter. Legal & General Group Plc now owns 1,756,429 shares of the medical technology company’s stock valued at $243,769,000 after acquiring an additional 78,126 shares during the last quarter. Finally, Swiss National Bank raised its holdings in Stryker by 1.0% in the 3rd quarter. Swiss National Bank now owns 1,711,871 shares of the medical technology company’s stock valued at $243,120,000 after acquiring an additional 17,300 shares during the last quarter. Institutional investors own 74.97% of the company’s stock.
In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the transaction, the insider now owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 7.40% of the company’s stock.
A number of analysts have recently issued reports on SYK shares. BidaskClub upgraded shares of Stryker from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Zacks Investment Research downgraded shares of Stryker from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. Oppenheimer restated a “hold” rating on shares of Stryker in a report on Wednesday, August 23rd. Canaccord Genuity restated a “buy” rating and set a $155.00 price target (down previously from $158.00) on shares of Stryker in a report on Thursday, August 24th. Finally, Piper Jaffray Companies restated an “overweight” rating and set a $148.00 price target on shares of Stryker in a report on Thursday, August 24th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $152.10.
Stryker Corporation (NYSE:SYK) traded down $3.51 during trading hours on Tuesday, hitting $152.36. 1,351,000 shares of the company were exchanged, compared to its average volume of 1,182,374. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.37 and a quick ratio of 1.61. The stock has a market cap of $58,332.41, a PE ratio of 24.70, a P/E/G ratio of 2.45 and a beta of 0.78. Stryker Corporation has a 1 year low of $111.22 and a 1 year high of $160.62.
Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. During the same quarter last year, the company posted $1.39 EPS. The firm’s quarterly revenue was up 6.1% on a year-over-year basis. equities analysts predict that Stryker Corporation will post 6.47 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Nordea Investment Management AB Acquires 2,954 Shares of Stryker Corporation (SYK)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/05/nordea-investment-management-ab-acquires-2954-shares-of-stryker-corporation-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.